PharmGKB summary: very important pharmacogene information for CYP4F2

被引:29
作者
Alvarellos, Maria L. [1 ]
Sangkuhl, Katrin [1 ]
Daneshjou, Roxana [1 ]
Whirl-Carrillo, Michelle [1 ]
Altman, Russ B. [1 ,2 ]
Klein, Teri E. [1 ]
机构
[1] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
关键词
arachidonic acid; eicosanoids; menaquinone; 4; pharmacogenomics; phylloquinone; -tocopherol; vitamin E; vitamin K; warfarin; B-4; OMEGA-HYDROXYLASE; WARFARIN DOSE REQUIREMENTS; VITAMIN-E; LEUKOTRIENE B-4; BLOOD-PRESSURE; HUMAN LIVER; 20-HYDROXYEICOSATETRAENOIC ACID; NONALCOHOLIC STEATOHEPATITIS; GENETIC-VARIANTS; COMMON VARIANTS;
D O I
10.1097/FPC.0000000000000100
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:41 / 47
页数:7
相关论文
共 63 条
  • [1] Oral anticoagulant drug interactions with statins: Case report of fluvastatin and review of the literature
    Andrus, MR
    [J]. PHARMACOTHERAPY, 2004, 24 (02): : 285 - 290
  • [2] Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials
    Athinarayanan, Shaminie
    Wei, Rongrong
    Zhang, Min
    Bai, Shaochun
    Traber, Maret G.
    Yates, Katherine
    Cummings, Oscar W.
    Molleston, Jean
    Liu, Wanqing
    Chalasani, Naga
    [J]. PLOS ONE, 2014, 9 (04):
  • [3] Common Variants of Cytochrome P450 4F2 Exhibit Altered Vitamin E-ω-Hydroxylase Specific Activity
    Bardowel, Sabrina A.
    Stec, David E.
    Parker, Robert S.
    [J]. JOURNAL OF NUTRITION, 2010, 140 (11) : 1901 - 1906
  • [4] Effects of CYP4F2 Polymorphism on Response to Warfarin During Induction Phase: A Prospective, Open-Label, Observational Cohort Study
    Bejarano-Achache, Idit
    Levy, Liran
    Mlynarsky, Liat
    Bialer, Meir
    Muszkat, Mordechai
    Caraco, Yoseph
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (04) : 811 - 823
  • [5] PREVALENCE OF HYPERTENSION IN THE US ADULT-POPULATION - RESULTS FROM THE 3RD NATIONAL-HEALTH AND NUTRITION EXAMINATION SURVEY, 1988-1991
    BURT, VL
    WHELTON, P
    ROCCELLA, EJ
    BROWN, C
    CUTLER, JA
    HIGGINS, M
    HORAN, MJ
    LABARTHE, D
    [J]. HYPERTENSION, 1995, 25 (03) : 305 - 313
  • [6] CYP4F2 genetic variant alters required warfarin dose
    Caldwell, Michael D.
    Awad, Tarif
    Johnson, Julie A.
    Gage, Brian F.
    Falkowski, Mat
    Gardina, Paul
    Hubbard, Jason
    Turpaz, Yaron
    Langaee, Taimour Y.
    Eby, Charles
    King, Cristi R.
    Brower, Amy
    Schmelzer, John R.
    Glurich, Ingrid
    Vidaillet, Humberto J.
    Yale, Steven H.
    Zhang, Kai Qi
    Berg, Richard L.
    Burmester, James K.
    [J]. BLOOD, 2008, 111 (08) : 4106 - 4112
  • [7] Genetic and Clinical Predictors of Warfarin Dose Requirements in African Americans
    Cavallari, L. H.
    Langaee, T. Y.
    Momary, K. M.
    Shapiro, N. L.
    Nutescu, E. A.
    Coty, W. A.
    Viana, M. A. G.
    Patel, S. R.
    Johnson, J. A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (04) : 459 - 464
  • [8] CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
    Cen, Han-Jing
    Zeng, Wu-Tao
    Leng, Xiu-Yu
    Huang, Min
    Chen, Xiao
    Li, Jia-Li
    Huang, Zhi-Ying
    Bi, Hui-Chang
    Wang, Xue-Ding
    He, Yan-Ling
    He, Fan
    Zhou, Rui-Na
    Zheng, Qi-Shan
    Zhao, Li-Zi
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 234 - 240
  • [9] Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
    Chalasani, Naga P.
    Sanyal, Arun J.
    Kowdley, Kris V.
    Robuck, Patricia R.
    Hoofnagle, Jay
    Kleiner, David E.
    Uenalp, Aynur
    Tonascia, James
    [J]. CONTEMPORARY CLINICAL TRIALS, 2009, 30 (01) : 88 - 96
  • [10] Menopause and hypertension - An age-old debate
    Coylewright, Megan
    Reckelhoff, Jane F.
    Ouyang, Pamela
    [J]. HYPERTENSION, 2008, 51 (04) : 952 - 959